Key facts
- This page summarizes Douglas Carr's Form 4 filing for Century Therapeutics, Inc. (IPSC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 15 Jun 2026, 19:56.
Douglas Carr - 12 Jun 2026 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)
- Reporting relationship
- SVP Finance & Operations
- Issuer ticker
- IPSC
- Reported as of
- 12 Jun 2026
- Net transaction value
- -$3,692
- SEC form
- 4
- Accepted by SEC
- 15 Jun 2026, 19:56:31 UTC
- Prior SEC filing
- 09 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Douglas Carr
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Douglas Carr filed Form 4 for Century Therapeutics, Inc. (IPSC) on 15 Jun 2026.
Change
- Previous filing in this sequence was filed on 09 Jun 2026.
- Current net transaction value: -$3,692.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001867173
Primary reporting owner
Carr Douglas
- Relationship
- SVP Finance & Operations
- Address
- C/O CENTURY THERAPEUTICS, INC., 25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA
- Signature
- /s/ Douglas Carr
- Signature date
- 15 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IPSC
transaction
Common Stock
Sale
- Transaction value
- $3,692
- Shares
- -1,654
- Change %
- -0.33%
- Price
- $2.23
- Shares after
- 505,094
- Date
- 12 Jun 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.